Further studies of intestinal mechanisms regulating pregnancy-associated changes in maternal insulin sensitivity and secretion are required, in order for us to make well-informed, evidence-based decisions to intervene and mitigate the impacts of maternal disease states, such as obesity and GDM, on glucose metabolism. Here, INS is linked to obesity disorder.